Welcome!
biotech
In print this week
Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff
SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.
August 31, 2018
Broker's Calls
This undervalued chemical player is a proxy to global economic growth, says SAC Advisors
SINGAPORE (June 26): SAC Advisors is starting coverage on Megachem at “buy” with a target price of 50 cents, which translates into 14.9 times FY19P/E to imply a 26% discount to the sector average.
June 26, 2018
Singapore’s tech & business services companies see highest levels of M&A activity
SINGAPORE (June 2): Singapore’s merger and acquisition (M&A) landscape saw a total of 56 deals worth US$13.8 billion ($19.1 billion) from Jan 2014 to April 2017, based on data compiled by Mergermarket Group, the media company specialising in corporate f
June 02, 2017